ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.19
-1.42%
US Tech 100
21,146.80
0.49%
S&P 500
6,013.13
-1.71%
US Dollar vs CAD
1.42135
-0.15%
Bitcoin
95,726.34
-0.57%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aquestive Therapeutics Inc (AQST)

  7. Aquestive Therapeutics Inc (AQST) News

AQST

Aquestive Therapeutics (AQST)

Aquestive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AQST
DateTimeSourceHeadlineSymbolCompany
02/20/20256:00AMGlobeNewswire Inc.Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
02/14/20255:12PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
02/12/20256:22AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
02/12/20256:00AMGlobeNewswire Inc.Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual MeetingNASDAQ:AQSTAquestive Therapeutics Inc
02/04/20256:00AMGlobeNewswire Inc.Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
01/24/20253:51PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AQSTAquestive Therapeutics Inc
01/13/20256:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
01/13/20256:00AMGlobeNewswire Inc.Aquestive Therapeutics Provides Business Update and Outlines Key 2025 ObjectivesNASDAQ:AQSTAquestive Therapeutics Inc
12/19/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
12/19/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to FiveNASDAQ:AQSTAquestive Therapeutics Inc
12/02/20247:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
12/02/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
11/27/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
11/14/20242:47PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
11/12/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Participate in Two Upcoming Investor ConferencesNASDAQ:AQSTAquestive Therapeutics Inc
11/08/20244:31PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AQSTAquestive Therapeutics Inc
11/07/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
11/06/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
11/04/20243:40PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
11/04/20243:36PMGlobeNewswire Inc.Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
10/25/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
10/25/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American CollegeNASDAQ:AQSTAquestive Therapeutics Inc
10/24/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
10/24/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
10/22/20245:06PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AQSTAquestive Therapeutics Inc
10/21/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
10/16/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
10/02/20241:16PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
10/02/20241:15PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
10/02/20241:15PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AQST

Your Recent History

COIN
XRPUSD
Ripple
NASDAQ
COOP
Mr Cooper
USOTC
AZRH
Azure (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
RDGL
Vivos (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NBRI
North Bay Resources (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
BIEL
Bioelectronics (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
HMBL
HUMBL (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads